The authorisation approximately triples the number of patients eligible to receive the therapy...
Better Therapeutics Competitors or Alternatives
Better Therapeutics's top competitors include dHealthIQ, WellDoc and Omada.
Better Therapeutics VS dHealthIQ
dHealthIQ is perceived as one of Better Therapeutics's biggest rivals. dHealthIQ was founded in 2015 in utrecht, Utrecht. dHealthIQ is in the Biotechnology field. dHealthIQ generates $ less revenue than Better Therapeutics.
Better Therapeutics VS WellDoc
WellDoc is Better Therapeutics's #2 rival. WellDoc is a Private company that was founded in 2005 in Columbia, Maryland. WellDoc competes in the Health Care Technology field. Compared to Better Therapeutics, WellDoc has 150 more employees.
Better Therapeutics VS Omada
Omada is one of Better Therapeutics's top competitors. Omada's headquarters is in San Francisco, California, and was founded in 2011. Like Better Therapeutics, Omada also operates in the Pharmaceuticals & Biotechnology industry. Omada generates 1,300,000% of Better Therapeutics's revenue.
Looking for similar companies to Better Therapeutics?
Similar Companies
Pharmaceuticals companies in San Francisco
See 120 companies
Pharmaceuticals companies in San Francisco Bay AreaSee 512 companies
Pharmaceuticals & Biotechnology companies in San FranciscoSee 386 companies
Pharmaceuticals companies in CaliforniaSee 1,457 companies
Pharmaceuticals & Biotechnology companies in San Francisco Bay AreaSee 1,673 companies
Pharmaceuticals companies with employees in 25-100 rangeSee 2,871 companies
Pharmaceuticals & Biotechnology companies in CaliforniaSee 4,181 companies
Pharmaceuticals & Biotechnology companies with employees in 25-100 rangeSee 7,072 companies
Pharmaceuticals companies in USASee 8,291 companies
Trending News for Better Therapeutics and Better Therapeutics's Competitors
NEW YORK, April 01, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Merck & Co., Inc. ("Merck" or the "Company") (NYSE:MRK) of a c...
NEW YORK, April 01, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in GSK plc ("GSK" or the "Company") GSK of a class action securit...
Positive results from the PURSUIT phase IIb trial for AstraZeneca's AZD0780 demonstrated a statistically significant low─density lipoprotein cholestero...
Novo Nordisk's stocks experienced the sharpest monthly decline since July 2002 due to growing competition and several disappointing trial results. Howe...
The US Food and Drug Administration approved Qfitlia (fitusiran) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adu...
The Phase II study found that lepodisiran significantly reduced levels of genetically inherited cardiovascular risk factor. The post Eli Lilly's lepodi...
NEW YORK, April 01, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Merck & Co., Inc. ("Merck" or the "Company") MRK of a class ac...
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In GSK To Contact Him Directly To Discu...
CHMP recommends Calquence plus chemoimmunotherapy for approval as the first BTK inhibitor for mantle cell lymphoma....
Frequently Asked Questions about Better Therapeutics
Who are Better Therapeutics's top competitors?
Better Therapeutics's top 3 competitors are dHealthIQ, WellDoc, Omada.Who is similar to Better Therapeutics?
dHealthIQ is the most similar to Better Therapeutics. WellDoc and Omada are also similar to Better Therapeutics.
Are Better Therapeutics and dHealthIQ competitors?
Yes, dHealthIQ is one of Better Therapeutics’s top competitors.